Phenotypical features of a heterozygous form of familial hypercholesterolemia

被引:0
|
作者
Malyshev, P. P.
Rozhkova, T. A.
Solovyeva, E. Yu.
Meshkov, A. N.
Kaminnaya, V. I.
Kukharchuk, V. V.
机构
关键词
familial hypercholesterolemia; xanthomas; cholesterol;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To conduct a quantitative and qualitative analysis of phenotypical manifestations in patients with a heterozygous form of familial hypercholesterolemia (FHC) and to reveal factors involved in their development. Material and methods. A total of 247 patients with a clinical diagnosis of heterozygous FHC participated in the trial. Clinical manifestations of the disease in men and women were analysed and compared. Blood lipids were compared to those in the controls. A correlation analysis was used to reveal correlations between symptoms of the disease and lipid levels in the blood. Results. Tendon xanthomas were most frequent (79916) clinical sign with location primarily in Achilles' tendon. Incidence of basic clinical manifestations increased with age and significantly correlated with LDLP cholesterol. Two clinical signs were seen in 113 of the patients, three - in 13% (sex differences were insignificant). Mean levels of total cholesterol and LDLP serum cholesterol in heterozygous patients were 1.9 and 2.5 times higher than in the controls. Total cholesterol was significantly higher in women. A mean level of HDLP cholesterol was significantly lower while triglycerides were higher than in the control group. The disease symptoms manifested in men 5 years earlier than in women, FHC was diagnosed in men 7 5 years earlier. Conclusion. Patients with heterozygous FHC are characterized by higher levels of LDLP cholesterol, lower level of HDLP cholesterol and higher triglycerides in the serum than in healthy controls. Sex-related differences by severity and prevalence of basic symptoms in heterozygous FHC patients were not found. The time of clinical symptoms appearance and diagnosis evidences for more rapid progression of the disease in men.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [41] ABNORMALITIES OF LIPOPROTEIN METABOLISM IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    JANUS, ED
    NICOLL, AM
    TURNER, PR
    WOOTTON, R
    LEWIS, B
    PATHOLOGY, 1980, 12 (01) : 140 - 140
  • [42] Heterozygous familial hypercholesterolemia presenting as chylomicronemia syndrome
    Rosenson, Robert S.
    Najera, Sherwin D.
    Hegele, Robert A.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (01) : 294 - 296
  • [43] Heterozygous familial hypercholesterolemia: Diagnosis and drug therapy
    Malyshev, PP
    KARDIOLOGIYA, 2000, 40 (10) : 63 - 69
  • [44] Peripheral arterial disease in heterozygous familial hypercholesterolemia
    Pereira, Carolina
    Miname, Marcio H.
    Makdisse, Marcia R. P.
    Watanabe, Carolina
    Pesaro, Antonio E.
    Jannes, Cinthia E.
    Kalil Filho, Roberto
    Pereira, Alexandre C.
    Santos, Raul D.
    ATHEROSCLEROSIS, 2015, 242 (01) : 174 - 178
  • [45] PORTACAVAL-SHUNT FOR FAMILIAL HETEROZYGOUS HYPERCHOLESTEROLEMIA
    MADRAS, PN
    SURGERY GYNECOLOGY & OBSTETRICS, 1981, 152 (02): : 187 - 190
  • [46] PREDICTORS OF CARDIOVASCULAR OUTCOMES IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA ACCORDING THE RUSSIAN FAMILIAL HYPERCHOLESTEROLEMIA REGISTRY
    Bliznyuk, S. A.
    Rozhkova, T. A.
    Ezhov, M. V.
    Tripoten, M. I.
    Pogorelova, O. A.
    Chubykina, U. V.
    Tmoyan, N. A.
    Balakhonova, T. V.
    Afanasieva, M. I.
    Afanasieva, O. I.
    Pokrovsky, S. N.
    ATHEROSCLEROSIS, 2020, 315 : E193 - E193
  • [47] GENETIC IDENTIFICATION OF HOMOZOGOUS FAMILIAL HYPERCHOLESTEROLEMIA AMONG PATIENTS WITH CLINICALLY DIAGNOSED HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Chaudhry, Ahsen
    Vesely, Kristin
    Trinder, Mark
    Brunham, Liam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1473 - 1473
  • [48] Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia
    Vuorio, AF
    Turtola, H
    Kontula, K
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 3332 - 3337
  • [49] When should patients with heterozygous familial hypercholesterolemia be treated?
    Rifkind, BM
    Schucker, B
    Gordon, DJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (02): : 180 - 181
  • [50] Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
    Nicholls, Stephen
    Nelson, Adam
    Ditmarsch, Marc
    Kastelein, John
    Ballantyne, Christie
    Ray, Kausik
    Navar, Ann Marie
    Nissen, Steven
    Goldberg, Anne
    Brunham, Liam
    Wuerdeman, Erin
    Neild, Annie
    Kling, Douglas
    Hsieh, Andrew
    Ference, Brian
    Laufs, Ulrich
    Banach, Maciej
    Mehran, Roxana
    Catapano, Alberico
    Davidson, Michael
    CIRCULATION, 2024, 150 (25) : E729 - E730